Rockwell Medical (RMTI)
(Delayed Data from NSDQ)
$1.49 USD
-0.04 (-2.61%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $1.46 -0.03 (-2.01%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
Balance Sheet
Fiscal Year End for Rockwell Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 11 | 21 | 22 | 59 | 26 |
Receivables | 11 | 6 | 6 | 4 | 4 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 6 | 6 | 4 | 4 | 4 |
Other Current Assets | 1 | 2 | 3 | 3 | 3 |
Total Current Assets | 29 | 35 | 35 | 69 | 37 |
Net Property & Equipment | 6 | 2 | 2 | 3 | 2 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 1 | 2 | 1 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 12 | 1 | 1 | 1 | 1 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 0 |
Total Assets | 52 | 47 | 49 | 78 | 44 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 4 | 4 | 4 | 3 |
Current Portion Long-Term Debt | 0 | 2 | 7 | 0 | 0 |
Current Portion Capital Leases | 1 | 0 | 0 | 0 | 0 |
Accrued Expenses | 7 | 8 | 5 | 5 | 5 |
Income Taxes Payable | 3 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 2 | 3 | 2 | 3 |
Total Current Liabilities | 17 | 18 | 21 | 13 | 12 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 3 | 3 | 6 | 8 | 10 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 8 | 8 | 13 | 21 | 0 |
Non-Current Capital Leases | 2 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 31 | 33 | 46 | 44 | 24 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 418 | 403 | 373 | 372 | 327 |
Retained Earnings | -397 | -389 | -370 | -337 | -307 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 21 | 14 | 3 | 34 | 20 |
Total Liabilities & Shareholder's Equity | 52 | 47 | 49 | 78 | 44 |
Total Common Equity | 21 | 14 | 3 | 34 | 20 |
Shares Outstanding | 28.40 | 12.10 | 8.50 | 8.50 | 5.80 |
Book Value Per Share | 0.75 | 1.17 | 0.30 | 4.02 | 3.50 |
Fiscal Year End for Rockwell Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 11 | 12 | 15 | 17 |
Receivables | NA | 11 | 9 | 5 | 6 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 6 | 5 | 6 | 6 |
Other Current Assets | NA | 1 | 2 | 1 | 1 |
Total Current Assets | NA | 29 | 28 | 28 | 30 |
Net Property & Equipment | NA | 6 | 7 | 2 | 2 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 1 | 1 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 12 | 12 | 1 | 1 |
Deposits & Other Assets | NA | 1 | 1 | 1 | 1 |
Total Assets | NA | 52 | 53 | 38 | 40 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 5 | 4 | 6 | 5 |
Current Portion Long-Term Debt | NA | 0 | 6 | 5 | 3 |
Current Portion Capital Leases | NA | 1 | 1 | 1 | 1 |
Accrued Expenses | NA | 7 | 7 | 4 | 4 |
Income Taxes Payable | NA | 3 | 3 | 0 | 0 |
Other Current Liabilities | NA | 1 | 1 | 1 | 0 |
Total Current Liabilities | NA | 17 | 21 | 17 | 15 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 3 | 3 | 2 | 3 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 8 | 3 | 5 | 6 |
Non-Current Capital Leases | NA | 2 | 2 | 2 | 2 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 31 | 31 | 29 | 28 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 418 | 417 | 403 | 403 |
Retained Earnings | NA | -397 | -396 | -394 | -391 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 21 | 22 | 10 | 13 |
Total Liabilities & Shareholder's Equity | NA | 52 | 53 | 38 | 40 |
Total Common Equity | 0 | 21 | 22 | 10 | 13 |
Shares Outstanding | 29.30 | 28.40 | 28.40 | 16.80 | 12.50 |
Book Value Per Share | 0.00 | 0.75 | 0.76 | 0.57 | 1.00 |